PRPH Share Price

Open 2.04 Change Price %
High 2.13 1 Day 0.06 2.91
Low 2.10 1 Week 0.09 4.43
Close 2.12 1 Month 0.08 3.92
Volume 9337 1 Year 0.92 76.67
52 Week High 2.45
52 Week Low 0.00
PRPH Important Levels
Resistance 2 2.15
Resistance 1 2.14
Pivot 2.12
Support 1 2.10
Support 2 2.09
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

ProPhase Labs, Inc. (NASDAQ: PRPH)

PRPH Technical Analysis 5
As on 24th Feb 2017 PRPH Share Price closed @ 2.12 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.73 & Strong Buy for SHORT-TERM with Stoploss of 2.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRPH Target for February
1st Target up-side 2.2
2nd Target up-side 2.41
3rd Target up-side 2.62
1st Target down-side 1.6
2nd Target down-side 1.39
3rd Target down-side 1.18
PRPH Other Details
Segment EQ
Market Capital 23589780.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
PRPH Address
PRPH
N/A
Interactive Technical Analysis Chart ProPhase Labs, Inc. ( PRPH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ProPhase Labs, Inc.
PRPH Business Profile
ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. The Company's primary business is manufacturing, distribution, marketing and selling of OTC cold remedy products to consumers through food, multi-outlet pharmacy and chain drug stores, wholesalers and mass merchandisers. The Company's brand is Cold-EEZEO Cold Remedy and the Company's principal product is Cold-EEZEO zinc gluconate lozenges, used to reduce the duration and severity of symptoms of the common cold. In August 2011, the Company launched Cold-EEZE Oral Spray.